Patents by Inventor Kyla Dee-Kinnick Kennedy

Kyla Dee-Kinnick Kennedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230021647
    Abstract: Provided herein are methods of treating a patient infected with a coronavirus and having a baseline level of CRP below 150 mg/L, comprising administering to the patient a compound of formula 1: or a pharmaceutically-acceptable salt thereof.
    Type: Application
    Filed: June 20, 2022
    Publication date: January 26, 2023
    Inventors: Rajeev Saggar, Tuan Stevon Nguyen, David A. Lombardi, Glenn D. Crater, Edmund J. Moran, Nathan David Pfeifer, Wayne Arthur Yates, Kyla Dee-Kinnick Kennedy, Joseph Budman, Arthur Lo
  • Publication number: 20210346357
    Abstract: Provided herein are methods of treating a patient infected with a coronavirus comprising administering to the patient a compound of formula 1: or a pharmaceutically-acceptable salt thereof.
    Type: Application
    Filed: May 7, 2021
    Publication date: November 11, 2021
    Applicant: Theravance Biopharma R&D IP, LLC
    Inventors: Glenn Douglas Crater, Edmund J. Moran, Rajeev Saggar, Nathan David Pfeifer, Wayne Arthur Yates, Kyla Dee-Kinnick Kennedy, Joseph Budman, Arthur Lo